Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.87NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.238NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.233NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.635NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.15.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used